<img src="https://ml-eu.globenewswire.com/Resource/Download/81292fcc-6b3a-4e4a-a083-ea4191bf920a?size=2" nborder="0" align="left" hspace="5" vspace="5" title="Ipsen Pharma" alt="Ipsen Pharma"/>CORRECTIVE STATEMENT Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026, published on July 9, 2026 Paris, July 22, 2026 This corrective statement is issued pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority (AMF). Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers) Market: Euronext Paris ISIN Code: FR 0010259150 LEI: 549300M6SGDPB4Z94P11 <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="width:13.6%;;text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; ">Date</td><td style="width:12.54%;;text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; ">Total number of shares composing the share capital</td><td style="width:23.86%;;text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; ">Total number of voting rights (1)</td></tr><tr><td rowspan="2" style="width:13.6%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; text-align: center ; vertical-align: middle; ">30 June 2026  </td><td rowspan="2" style="width:12.54%;;text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; text-align: center ; vertical-align: middle; ">83,814,526  </td><td style="width:23.86%;;text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; ">Gross total* of voting rights: 132,090,665</td></tr><tr><td style="width:23.86%;;text-align: center ; vertical-align: middle; border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; vertical-align: middle ; ">Net total** of voting rights: 130,884,189</td></tr></table> (1) Existence of a statutory clause imposing an obligation to declare threshold crossing complementary to the one relative to the legal thresholds (Article 10). * Gross total = total number of voting rights attached to the total number of shares, including the number of shares which benefit of double voting rights and the number of treasury shares. The « Gross total » is used as a basis for the calculation of threshold crossings. ** Net total = total number of voting rights attached to the total number of shares – shares without voting rights. Reason for the correction A material error affecting the total number of theoretical (gross) voting rights and the total number of exercisable (net) voting rights was identified after publication. The corrected figures are set out above. 
 Attachment

<ul id="gnw_attachments_section-items">
 <li>
 <a target="_blank" href="https://www.globenewswire.com/Tracker?data=fOUoHC6dkF-09y4xbc7SZNPAVrnvo1DYf8ySSPCLnLKKHdKqstBC9wuxbPDc63sPiB8V0Ev2yMlCl7s5hY-C5gghm0Xm_T3PyIlW2O_gt58bbb6DzubPqcV_ELemr9lS9n_jnzJ-OmV9ZX2slPLN1JAx9oLY70bF5OfaNAawIm02Y3ezzO1Re70NxCoJGveSRUpWA7_7MlBGgqQwZ4XMXTXmhvhQOekKu-pvXrlUfgpHDU2mbfIoWdPjFt-jEsEb" title="_Correction_Declaration relative to the total number of voting rights - June 2026" rel="nofollow">_Correction_Declaration relative to the total number of voting rights - June 2026</a>
 </li>
 </ul>
 <img alt="" src='https://ml-eu.globenewswire.com/media/NDNjZThlZjItMTUzOC00NjNmLWFkMGItNWNiZDU5NzczZWFkLTEyNjgxMTYtMjAyNi0wNy0yMi1lbg==/tiny/Ipsen-Pharma.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn